Diffuse large B-cell #lymphoma is typically a fast-growing, aggressive type of non-Hodgkin lymphoma. It affects immune cells called B lymphocytes, a type of white blood cell. | Bristol Myers Squibb

Today, the FDA granted accelerated approval for a new targeted medicine that treats the most aggressive form of #lymphoma. Watch our video to learn more about diffuse large B-cell lymphoma (DLBCL): http://bit.ly/2I5sd5L | Genentech

149K views · 680 reactions | Diagnosed with stage 4 lung cancer, K.c. Ashabranner Dill's outlook was not positive. But after being treated with immunotherapy at Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, her cancer disappeared – recent scans show no evidence of the disease. #CIM18 | Cancer Research Institute | Facebook

Meet Lena, a survivor who faced stage 1 diffuse large B-cell lymphoma (DLBCL) head-on, and now, she shares her incredible journey from pre-diagnosis to life after cancer. It all began with what seemed like symptoms of a UTI—blood in her urine. Further investigations uncovered a bladder tumor. Unexpectedly, DLBCL was diagnosed post-surgery, despite the absence of typical signs. Lena candidly recounts the challenges of chemotherapy, from severe medication reactions to the emotional impact of hair